Price T Rowe Associates Inc Mannkind Corp Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Mannkind Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 241,096 shares of MNKD stock, worth $882,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241,096

Previous 201,317 19.76%

Holding current value

$882,411

Previous $1.01 Million 10.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.71 - $5.04 $147,580 - $200,486	39,779 Added 19.76%	241,096 $902,000
Q1 2025 May 14, 2025	BUY	$4.92 - $6.6 $129,435 - $173,632	26,308 Added 15.03%	201,317 $1.01 Million
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.44 $111,519 - $139,916	18,806 Added 12.04%	175,009 $1.13 Million
Q3 2024 Nov 14, 2024	SELL	$5.01 - $6.7 $172,629 - $230,861	-34,457 Reduced 18.07%	156,203 $983,000
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $75,354 - $101,030	18,606 Added 10.81%	190,660 $996,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $30,582 - $49,590	9,410 Added 5.79%	172,054 $780,000
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $171,402 - $220,154	51,318 Added 46.1%	162,644 $593,000
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $131,160 - $182,820	-33,545 Reduced 23.16%	111,326 $460,000
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $39,934 - $51,420	10,735 Added 8.0%	144,871 $590,000
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $17,498 - $24,940	-4,430 Reduced 3.2%	134,136 $550,000
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $16,223 - $28,847	5,372 Added 4.03%	138,566 $730,000
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $44,631 - $64,932	14,927 Added 12.62%	133,194 $412,000
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $17,491 - $31,248	6,551 Added 5.86%	118,267 $451,000
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $48,797 - $82,881	18,625 Added 20.01%	111,716 $411,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $19,853 - $26,323	-4,902 Reduced 5.0%	93,091 $407,000
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $1,167 - $1,644	300 Added 0.31%	97,993 $426,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $21,609 - $32,623	5,986 Added 6.53%	97,693 $532,000
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $157,593 - $308,160	50,189 Added 120.88%	91,707 $359,000
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $74,317 - $167,732	41,518 New	41,518 $130,000

Others Institutions Holding MNKD

# of Institutions

248

Shares Held

161M

Call Options Held

1.24M

Put Options Held

183K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $942M
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Mannkind Corp Transaction History